Using in vivo biotinylated ubiquitin to describe a mitotic exit ubiquitome from human cells.
about
KIFC1: a promising chemotherapy target for cancer treatment?Ubiquitin-Mediated Degradation of Aurora KinasesGlobal Phosphoproteomic Mapping of Early Mitotic Exit in Human Cells Identifies Novel Substrate Dephosphorylation MotifsPhosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic SignalingQuantitative proteomic analysis of Parkin substrates in Drosophila neurons.Proteomic Analysis of the Ubiquitin Landscape in the Drosophila Embryonic Nervous System and the Adult Photoreceptor Cells.Efficient APC/C substrate degradation in cells undergoing mitotic exit depends on K11 ubiquitin linkagesProteomic techniques to probe the ubiquitin landscape.Mechanisms regulating phosphatase specificity and the removal of individual phosphorylation sites during mitotic exit.Ubiquitination site preferences in anaphase promoting complex/cyclosome (APC/C) substrates.Proteomics in Cell Division.Visualizing the complex functions and mechanisms of the anaphase promoting complex/cyclosome (APC/C).Isolation of Ubiquitinated Proteins to High Purity from In Vivo Samples.SUMO targets the APC/C to regulate transition from metaphase to anaphase.Neuronal Proteomic Analysis of the Ubiquitinated Substrates of the Disease-Linked E3 Ligases Parkin and Ube3a.Coordination of Protein Kinase and Phosphoprotein Phosphatase Activities in Mitosis.An E2-ubiquitin thioester-driven approach to identify substrates modified with ubiquitin and ubiquitin-like molecules
P2860
Q26751207-EA78A117-9CAF-42DB-B51C-1E95A2E34C6CQ26770280-8B9878B3-C689-48D8-A058-BEC3298D0762Q27311643-EFB853FB-D9DA-484A-85C2-4D03FE90CE97Q28551996-B1E5152A-D1E2-4B0F-91EE-37A3628FB1B1Q30844860-CDBD52A0-8E45-4403-A68C-A75259D02DE8Q35804599-3B8BE028-5441-4245-A980-96493F2B46C2Q36336999-7F3B831C-DE2B-4604-8DB5-322B3A79314FQ38605568-3C3D45A6-1D33-46B2-BF9C-B858DBDE5808Q38896918-0F6DB39C-7F72-43FA-BAC0-1198131BABC2Q39100315-DDB793B5-59E8-45C0-8FD2-11F193F9DA83Q39332519-F12818F2-7739-4914-98A5-90006FC9F222Q47105112-4A68DBE1-8C2D-4899-B452-9455F81DF51CQ51524414-22FBC116-CF18-4A13-BBC8-553CED3E8486Q52352276-4180E08E-7D01-4660-8C6E-0B3A361260A0Q52564493-1A197EC2-A108-4DE0-982D-7D189F9E64E3Q52721214-94A04E34-BA57-4BF3-9CE2-DB5F42C4FD3FQ59137306-DC9254EC-E727-482F-8A31-B4DF80C8EA23
P2860
Using in vivo biotinylated ubiquitin to describe a mitotic exit ubiquitome from human cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Using in vivo biotinylated ubi ...... t ubiquitome from human cells.
@en
type
label
Using in vivo biotinylated ubi ...... t ubiquitome from human cells.
@en
prefLabel
Using in vivo biotinylated ubi ...... t ubiquitome from human cells.
@en
P2860
P50
P356
P1476
Using in vivo biotinylated ubi ...... it ubiquitome from human cells
@en
P2093
Mingwei Min
P2860
P304
P356
10.1074/MCP.M113.033498
P577
2014-05-25T00:00:00Z